Microbiome Alliance for Disease Prevention (MADP) is a national 501(c)(3) non-profit organization advancing early detection and prevention ~ breaking down barriers to end chronic disease. We are dedicated to bringing forth the latest advancements in clinical testing, preventive measures, and targeted treatments to best support patients, healthcare providers, and community health outreach.
Precision, prevention, and early detection are opening the door to realign the way we look at health, how we treat patients, and how we combat disease. MADP addresses the critical drivers of non-communicable chronic diseases (NCDs) such as heart disease, diabetes, and cancer utilizing precision medicine, the microbiome, and precision nutrition ~ MADP Precision Public Health.
Precision Medicine is a fundamental part of preventive healthcare ~ facilitating early detection and targeted treatments. It takes into account individual differences in patients’ genes, nutrition, environment, lifestyle, and the microbiome.
Leveraging smarter preventive screening detects disease at its earliest, most treatable stages – enabling faster diagnoses and earlier interventions to improve health outcomes.
For patients, navigating the complex clinical field can be overwhelming. Understanding the drivers of disease, the importance of early detection, and the adoption of preventive measures, is crucial for informed decisions and active participation in one’s own medical care.
We are unwavering in our commitment to patients and providers providing helpful education and critical supportive resources from smarter preventive screening tests at your next annual exam to navigating the complex world of tumor biomarkers for cancer patients ~ MADP ensures everyone benefits from the promise of precision healthcare.
MADP operates as a COLLABORATIVE ALLIANCE partnering with top medical institutions, clinicians, and researchers from across the country. TOGETHER we break down barriers to bring hope – today, tomorrow, and generations to come.
Chronic diseases are the leading cause of mortality in the U.S. and worldwide, posing a significant public health challenge. It is likely that you or someone you care about has been diagnosed with heart disease, cancer, diabetes, obesity, autoimmune disease, inflammatory bowel disease, or dementia. The majority of chronic diseases progress slowly over multiple years before physical symptoms arise.
Atherosclerosis, for instance, is a gradual process that starts decades prior to developing into heart disease. It can begin as early as the teenage years, progressing slowly through 20’s and 30’s. It is often silent until there is significant artery narrowing or cardiac event later in life.
Various factors, including lifestyle choices, genetic predisposition, and underlying medical conditions, influence the rate at which atherosclerosis develops ~ underscoring the importance of preventive measures and early detection.
Chronic inflammation – a ‘silent’ driver of chronic disease:
When battling cancer, every minute matters. MADP is dedicated to supporting cancer patients throughout their journey. We provide comprehensive resources to help patients navigate the complex world of cancer, offering a hopeful approach to understanding the disease and accessing essential care.
MADP collaborates with leading cancer researchers, oncologists, and precision medicine experts to deliver the latest advancements in cancer detection, tumor biomarker testing, and targeted treatments.
We are deeply grateful for their knowledge, expertise, personal cancer survivorship, and commitment to assisting others through MADP’s public health non-profit. Their efforts help us break down barriers and provide critical supportive resources.
MADP Circle of Hope supports individuals recently diagnosed, those undergoing treatment, and cancer survivors. MADP Circle of Hope is here for you Together Fighting Cancer – Every Step of the Way.
Jonathan Peled, MD, Ph.D., Medical Oncologist, Memorial Sloan Kettering Cancer Center.
Justin Sonnenburg, Ph.D., Erica Sonnenburg, Ph.D., and other collaborators, Stanford School of Medicine.
Geoffrey von Maltzahn, Ph.D., Flagship Pioneering, Singularity University Global Summit, A Microbiome Revolution.